smartbax
ID: 16459898smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
2
Funding Rounds
$6.8m
Money raised
Recent Funding Rounds
Overview
smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Website:
- Headquarters: Munich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** Ma***** |
|
- | |
| St***** Si**** |
|
- | |
| Ma*** Ja***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company smartbax has raised a total of $6.8m in funding over 2 rounds.
Key Insights:
- smartbax Seed Round, October 2025: $5.5m
- smartbax May 2023 Seed Funding Round: $1.3m